Search

Your search keyword '"Kang, Chang Kyung"' showing total 370 results

Search Constraints

Start Over You searched for: Author "Kang, Chang Kyung" Remove constraint Author: "Kang, Chang Kyung"
370 results on '"Kang, Chang Kyung"'

Search Results

55. 208. Clinical outcomes of empirical versus pre-emptive broad spectrum antifungal therapy in patients with acute myelogenous leukemia receiving antimold prophylaxis

56. Tracking antigen‐specific TCR clonotypes in SARS‐CoV‐2 infection reveals distinct severity trajectories.

57. Accurate Diagnosis of COVID-19 from Self-Collectable Biospecimens Using Synthetic Apolipoprotein H Peptide-Coated Nanoparticle Assay

58. Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer

60. Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment

61. Clinical impact of clonal hematopoiesis on severe COVID- 19 patients without canonical risk factors

62. SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients

63. Evaluation of Seropositivity after Standard Doses of Vaccination against SARS-CoV-2 in Early Breast Cancer Patients Receiving Adjuvant Treatment

64. Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity

65. Corrigendum: Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity

67. Corrigendum to: Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

68. Additional file 2 of Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection

69. Additional file 5 of Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection

70. Additional file 3 of Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection

71. Additional file 1 of Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection

72. Additional file 4 of Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection

76. Workload of Healthcare Workers During the COVID-19 Outbreak in Korea: A Nationwide Survey

77. Changes in Anxiety Level and Personal Protective Equipment Use Among Healthcare Workers Exposed to COVID-19

78. Exploration for the effect of renal function and renal replacement therapy on pharmacokinetics of remdesivir and GS‐441524 in patients with COVID‐19: A limited case series

79. Can reactogenicity predict immunogenicity after COVID-19 vaccination?

80. Clinical and immunological signatures of severe COVID-19 in previously healthy patients with clonal hematopoiesis

82. Additional file 1 of Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients

84. Mapping the human genetic architecture of COVID-19

85. Investigation of transmission rate of carbapenemase-producing carbapenem-resistant Enterobacteriaceae among contacted patients and healthcare workers in a tertiary hospital

86. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

87. Stereotypic neutralizing V H antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals

88. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19

92. Antibody Responses One Year after Mild SARS-CoV-2 Infection

94. Clonal hematopoiesis is associated with risk of severe Covid-19

95. 1147. Short Course of Voriconazole Therapy as a Risk Factor for Relapse of Invasive Pulmonary Aspergillosis

96. 1605. Differences in Clinical Characteristics of Third Generation Cephalosporin Resistance and Treatment Outcomes in Escherichia coli and Klebsiella pneumoniae Bacteremia in Patients with Liver Cirrhosis

97. 813. The Reduction of the acquisition rate of carbapenem resistant Acinetobacter baumannii after room privatization in the intensive care unit

98. Immunogenicity and Safety of a Live Herpes Zoster Vaccine in Hematopoietic Stem Cell Transplant Recipients

100. Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea

Catalog

Books, media, physical & digital resources